| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.072 | 0.01 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.02 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.073 | 0.02 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.072 | 0.02 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.02 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.083 | 0.02 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.02 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | 0.07 | 0.02 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.077 | 0.02 |